Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VERACYTE, INC. | Chief Financial Officer | Common Stock | 125K | $4.77M | $38.34 | Nov 12, 2024 | Direct |
Inari Medical, Inc. | Director | Common Stock | 9.68K | $445K | $45.99 | Jun 21, 2024 | Direct |
Outset Medical, Inc. | Chief Financial Officer | Common Stock | 13.6K | $58.3K | $4.29 | Jun 24, 2021 | Direct |
Outset Medical, Inc. | Chief Financial Officer | Non-Qualified Stock Option (right to buy) | 77.7K | Jun 24, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VCYT | VERACYTE, INC. | Nov 12, 2024 | 1 | -$586K | 4 | Nov 14, 2024 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Sep 2, 2024 | 1 | -$109K | 4 | Sep 4, 2024 | Chief Financial Officer |
NARI | Inari Medical, Inc. | Jun 21, 2024 | 1 | -$12K | 4 | Jun 24, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 2, 2024 | 1 | -$71.8K | 4 | Jun 4, 2024 | Chief Financial Officer |
NARI | Inari Medical, Inc. | May 20, 2024 | 1 | -$43.8K | 4 | May 21, 2024 | Director |
NARI | Inari Medical, Inc. | Apr 24, 2024 | 1 | $175K | 4 | Apr 26, 2024 | Director |
VCYT | VERACYTE, INC. | Mar 15, 2024 | 2 | -$46.2K | 4 | Mar 19, 2024 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Mar 2, 2024 | 1 | -$147K | 4 | Mar 5, 2024 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Dec 2, 2023 | 1 | -$47.8K | 4 | Dec 5, 2023 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Sep 2, 2023 | 1 | -$97.5K | 4 | Sep 6, 2023 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Jun 2, 2023 | 1 | -$31.6K | 4 | Jun 6, 2023 | Chief Financial Officer |
NARI | Inari Medical, Inc. | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
VCYT | VERACYTE, INC. | Mar 6, 2023 | 2 | $0 | 4 | Mar 9, 2023 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Mar 2, 2023 | 1 | -$65.7K | 4 | Mar 3, 2023 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Dec 2, 2022 | 1 | -$21.4K | 4 | Dec 6, 2022 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Sep 2, 2022 | 1 | -$58K | 4 | Sep 7, 2022 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Aug 5, 2022 | 2 | $0 | 4 | Aug 9, 2022 | Chief Financial Officer |
NARI | Inari Medical, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
VCYT | VERACYTE, INC. | Mar 3, 2022 | 2 | $0 | 4 | Mar 7, 2022 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Jul 19, 2021 | 2 | $0 | 4 | Jul 20, 2021 | Chief Financial Officer |
VCYT | VERACYTE, INC. | Jul 19, 2021 | 0 | $0 | 3 | Jul 20, 2021 | Chief Financial Officer |
OM | Outset Medical, Inc. | Jun 24, 2021 | 3 | -$744K | 4 | Jun 25, 2021 | Chief Financial Officer |
NARI | Inari Medical, Inc. | Jun 21, 2021 | 0 | $0 | 3 | Jun 22, 2021 | Director |
NARI | Inari Medical, Inc. | Jun 21, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
OM | Outset Medical, Inc. | May 25, 2021 | 3 | -$650K | 4 | May 26, 2021 | Chief Financial Officer |